Osaka Medical and Pharmaceutical University · Faculty of Medicine / Graduate School of Medicine

Research keywordsInternal・medicine・Oncology・Cancer

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab: A Multicenter Retrospective Study.2024 · Clinical genitourinary cancer / 22 / 1
• Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on Neutrophil-Lymphocyte Ratio Fluctuation and Liver Metastases.2024 · Oncology / 102 / 6
• Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival.2023 · Clinical and translational radiation oncology / 39
• Tertiary lymphoid structure and neutrophil-lymphocyte ratio coordinately predict outcome of pembrolizumab.2023 · Cancer science / 114 / 12

• Official profile